CD4 and neoplasm: We found that several protein biomarkers, most notably panCK, IDO1, CD44, and Ki-67, were expressed at higher levels in responders’ tumor compartments; however, in the stroma, SMA, Fibronectin, CD4, and CD27 were the most differentially expressed (Figure 7A).